General Information
BounceWatch is an independent company data service, not affiliated with Abpro . To contact Abpro , visit abpro.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Abpro compare?
A PDF of Abpro and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Abpro soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Abpro on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Abpro
Business keywords: Antibody Therapeutics, Immuno-Oncology, Ophthalmology, Reagents, Biochemistry, Recombinant Proteins, Collaborations, Therapeutic Antibodies, Cancer Research, Infectious Diseases, T-Cell Engagers, Wet AMD, DME, Bi-Specific Antibodies
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $18.00M | - |
|
27 Jan 2020 |
| Venture Round | $10.00M | - |
|
07 Apr 2017 |
| Venture Round | $12.39M | - |
|
23 Mar 2016 |
Abpro Alternatives & Competitors
View All AlternativesMerus was acquired by Genmab. To see what’s new, visit Genmab.
Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...
Innovation Focused Outcomes Driven
FAQ About Abpro
Source: BounceWatch company record for Abpro , https://www.bouncewatch.com/company/abpro, updated 4 January 2025. When citing, please name BounceWatch and link this page.